SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-010571
Filing Date
2024-03-19
Accepted
2024-03-19 21:49:03
Documents
1
Period of Report
2024-03-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4089
  Complete submission text file 0001493152-24-010571.txt   5604
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Issuer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 902 BROADWAY, 15TH FLOOR NEW YORK NY 10010
Business Address
Barr Jason Michael (Reporting) CIK: 0001645550 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21617 | Film No.: 24766183